                         SEQUENCE LISTING

<110>  Cashman, Daniel P
 
<120>  VIRUS TREATMENT METHODS, AND RELATED PHARMACEUTICAL COMPOSITIONS,
        VACCINE COMPOSITIONS, SANITIZING COMPOSITIONS, AND DRUG 
       DISCOVERY METHODS

<130>  DC.001 PC

<140>  PCT/US2021/025122
<141>  2021-03-31

<150>  US 63/003,007
<151>  2020-03-31

<150>  US 63/033,274
<151>  2020-06-02

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  PRT
<213>  SARS-COV-2

<400>  1

Ser Phe Ile Glu Asp Leu Leu Phe Asn Lys Val Thr Leu Ala Asp Ala 
1               5                   10                  15      


Gly Phe Ile Lys Gln Tyr 
            20          


<210>  2
<211>  22
<212>  PRT
<213>  SARS-COV-1

<400>  2

Ser Phe Ile Glu Asp Leu Leu Phe Asn Lys Val Thr Leu Ala Asp Ala 
1               5                   10                  15      


Gly Phe Met Lys Gln Tyr 
            20          


<210>  3
<211>  21
<212>  PRT
<213>  SARS-COV-2

<400>  3

Lys Gln Tyr Gly Asp Cys Leu Gly Asp Ile Ala Ala Arg Asp Leu Ile 
1               5                   10                  15      


Cys Ala Gln Lys Phe 
            20      


<210>  4
<211>  21
<212>  PRT
<213>  SARS-COV-1

<400>  4

Lys Gln Tyr Gly Glu Cys Leu Gly Asp Ile Asn Ala Arg Asp Leu Ile 
1               5                   10                  15      


Cys Ala Gln Lys Phe 
            20      


<210>  5
<211>  7
<212>  PRT
<213>  SARS-COV-2

<400>  5

Gly Asp Ile Ala Ala Arg Asp 
1               5           


<210>  6
<211>  7
<212>  PRT
<213>  Rubella virus

<400>  6

Gly Asp Asp Ser Gly Arg Asp 
1               5           


<210>  7
<211>  6
<212>  PRT
<213>  HCoV-229E

<400>  7

Lys Arg Tyr Gly Phe Cys 
1               5       


